AstraZeneca
Immunai, AstraZeneca collaborate to optimize cancer clinical trials
Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.
US to move COVID-19 vaccines, treatments to private markets in 2023
AION, aMoon up for top scientific innovation award
COVID-19 booster shots are crucial, according to a Yale study
Britain approves AstraZeneca’s COVID-19 vaccine for emergency supply
AstraZeneca and other developers have said they are studying the impact of the new variant but expect that their shots will be effective against it.
Antibody study aims to protect those exposed to coronavirus from illness
Two studies will examine whether an antibody combination reduces the risk of developing COVID-19 and/or reduces the severity of the infection compared to a placebo.
AstraZeneca COVID-19 vaccine trial results likely in late-Jan
The British drugmaker and Oxford University have already published interim efficacy results from their UK trial in November, but the results have raised questions among scientists.
Where Do MENA Countries Stand in Securing COVID-19 Vaccines?
The latest COVID-19 information and statistics for the Middle East and North Africa
AstraZeneca likely to run new global trial on COVID-19 vaccine – report
Israel’s vaccine delivery could be delayed.
AstraZeneca must prove claim to cheapest COVID-19 vaccine
AstraZeneca had no immediate comment on the matter.
AstraZeneca signals more good vaccine news - but efficacy only beginning
When clinical trials report their results — and the media follow — the correct term is “efficacy”, rather than “effectiveness”.
Israel to sign for 10 million doses of AstraZeneca’s coronavirus vaccine
This is the largest amount of vaccines from any one company to be sold to Israel.
AstraZeneca COVID-19 vaccine shows promise in elderly, trial results by Christmas
Results of late-stage trials of University of Oxford's COVID-19 vaccine candidate should definitely be known by Christmas.
Canada in talks to donate extra COVID-19 vaccines to poorer countries
The approach could undermine efforts to ensure vaccines are distributed fairly around the world, depending on whether certain funding and research goals are met.
